Expert commentary
"PSA testing remains the cornerstone of detecting prostate cancer early, and we now have stronger evidence of its benefits," stated Robert Smith, MD, senior vice president, early cancer detection science, and director, Center for Early Cancer Detection at the American Cancer Society and senior author of the report. "We also have better approaches to catching lethal tumors while avoiding unnecessary tests for slow-growing cancers that may never need aggressive care."
Dr. Ed Trabulsi, a urologist with Jefferson Health, told 69 News that screenings typically involve a prostate-specific antigen, or PSA blood test. "It's a very important update that strengthens the guidelines to utilize the PSA blood test to really try to catch prostate cancer early," Trabulsi stated.
Simpa Salami, M.D., M.P.H., of the University of Michigan Rogel Cancer Center, said: "The updated ACS guidelines are an important step forward — they signal that we can no longer afford a one size fits all approach to prostate cancer screening."